Loading...
XTAE
ALBA
Market cap175mUSD
Dec 04, Last price  
3,043.00ILS
1D
1.43%
1Q
13.93%
Jan 2017
-45.24%
Name

Al-Bad Massuot Yitzhak Ltd

Chart & Performance

D1W1MN
XTAE:ALBA chart
P/E
12.64
P/S
0.33
EPS
2.41
Div Yield, %
Shrs. gr., 5y
7.35%
Rev. gr., 5y
3.97%
Revenues
1.72b
+0.54%
507,497,000584,021,000636,348,000680,772,000689,243,0001,382,850,0001,412,693,0001,445,240,0001,493,762,0001,510,455,0001,454,508,0001,504,701,0001,415,282,0001,578,936,0001,485,911,0001,453,877,0001,710,479,0001,719,768,000
Net income
45m
+48.49%
23,681,00015,905,00017,449,00023,090,00022,274,00030,897,00015,973,00066,996,00040,227,00054,584,00033,766,000-32,938,000-64,709,000101,310,000-20,340,000-35,123,00030,227,00044,885,000
CFO
153m
-34.61%
4,803,00023,962,00019,525,00039,605,00028,465,000124,489,000112,496,00078,521,00090,716,000118,740,00070,182,00085,181,00097,123,000184,721,00052,579,00018,568,000233,229,000152,502,000
Dividend
Nov 05, 2020191.11455 ILS/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Albaad Massuot Yitzhak Ltd produces and sells wipes worldwide. It offers cleaning hand wipes including disinfecting and antibacterial wipes; cosmetic wipes, such as facial care, body, and feet care wipes; feminine hygienic product, which include tampons; and baby, maternity, toddler, and household cleaning wipes. The company also provides professional wipes, such as para-medical, veterinary, automotive, and restaurant wipes, as well as sachets; adult wipes including adult bed and bath; personal care wipes, which include intimate wipes; para-pharma wipes and flushable moist toilet paper product. In addition, it offers contract, private label, and institutional manufacturing services. The company was founded in 1985 and is based in Nir Yitzhak, Israel.
IPO date
Jan 01, 1994
Employees
1,994
Domiciled in
IL
Incorporated in
IL

Valuation

Title
ILS in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT